Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway

Liu,Ming; Wang,Jian; Huang,Bin; Chen,Anjing; Li,Xingang

doi:10.3892/or.2016.4978

Oleuropein inhibits the proliferation and invasion of glioma cells via suppression of the AKT signaling pathway

Authors:
- Ming Liu
- Jian Wang
- Bin Huang
- Anjing Chen
- Xingang Li
View Affiliations

Affiliations: Department of Neurosurgery, Qilu Hospital of Shandong University and Brain Science Research Institute, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: July 28, 2016 https://doi.org/10.3892/or.2016.4978
Pages: 2009-2016

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oleuropein, the main phenolic compound of secoiridoids, has been proven to have inhibitory effects on various types of cancers. However, the antitumor effects and related mechanisms in glioma remain unclear. In the present study, U251 and A172 cells were used to assess the effects of oleuropein. Using cell viability assay, we found that oleuropein greatly inhibited the viability of the U251 and A172 cells. Additionally, flow cytometric apoptosis assay indicated that oleuropein induced the apoptosis of the two cell lines. Consistently, the inhibitory effects of oleuropein on migration and invasion were also observed in vitro. In regards to the mechanism, we found that oleuropein significantly decreased phosphorylation of AKT (p-AKT), accompanied by upregulation of Bax and downregulation of Bcl-2. We also found that there was a decrease in the expression levels of matrix metalloproteinase-2 (MMP-2) and MMP-9 after treatment with oleuropein. Furthermore, a specific phosphatidylinositol 3 kinase (PI3K) inhibitor, LY294002, enhanced the pro-apoptotic and anti-invasive effects induced by oleuropein, which suggested that oleuropein suppressed the growth and invasion of glioma cells via inhibition of AKT activity. Taken together, our results indicated that treatment with oleuropein may be an effective therapy for malignant glioma through suppression of tumor proliferation and invasion by inhibition of the AKT signaling pathway.

View Figures

View References

1	Fisher PG and Buffler PA: Malignant gliomas in 2005: Where to GO from here? JAMA. 293:615–617. 2005. View Article : Google Scholar : PubMed/NCBI
2	Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K and Delattre JY: Primary brain tumours in adults. Lancet. 379:1984–1996. 2012. View Article : Google Scholar : PubMed/NCBI
3	Rock K, McArdle O, Forde P, Dunne M, Fitzpatrick D, O'Neill B and Faul C: A clinical review of treatment outcomes in glioblastoma multiforme - the validation in a non-trial population of the results of a randomised Phase III clinical trial: Has a more radical approach improved survival. Br J Radiol. 85:729–733. 2012. View Article : Google Scholar
4	Coni E, Di Benedetto R, Di Pasquale M, Masella R, Modesti D, Mattei R and Carlini EA: Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits. Lipids. 35:45–54. 2000. View Article : Google Scholar : PubMed/NCBI
5	Visioli F, Caruso D, Galli C, Viappiani S, Galli G and Sala A: Olive oils rich in natural catecholic phenols decrease isoprostane excretion in humans. Biochem Biophys Res Commun. 278:797–799. 2000. View Article : Google Scholar : PubMed/NCBI
6	Aziz NH, Farag SE, Mousa LA and Abo-Zaid MA: Comparative antibacterial and antifungal effects of some phenolic compounds. Microbios. 93:43–54. 1998.PubMed/NCBI
7	Bisignano G, Tomaino A, Lo Cascio R, Crisafi G, Uccella N and Saija A: On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol. J Pharm Pharmacol. 51:971–974. 1999. View Article : Google Scholar : PubMed/NCBI
8	Micol V, Caturla N, Pérez-Fons L, Más V, Pérez L and Estepa A: The olive leaf extract exhibits antiviral activity against viral haemorrhagic septicaemia rhabdovirus (VHSV). Antiviral Res. 66:129–136. 2005. View Article : Google Scholar : PubMed/NCBI
9	Lee-Huang S, Zhang L and Huang PL, Chang YT and Huang PL: Anti-HIV activity of olive leaf extract (OLE) and modulation of host cell gene expression by HIV-1 infection and OLE treatment. Biochem Biophys Res Commun. 307:1029–1037. 2003. View Article : Google Scholar : PubMed/NCBI
10	Bazoti FN, Bergquist J, Markides KE and Tsarbopoulos A: Noncovalent interaction between amyloid-beta-peptide (1–40) and oleuropein studied by electrospray ionization mass spectrometry. J Am Soc Mass Spectrom. 17:568–575. 2006. View Article : Google Scholar : PubMed/NCBI
11	Mijatovic SA, Timotijevic GS, Miljkovic DM, Radovic JM, Maksimovic-Ivanic DD, Dekanski DP and Stosic-Grujicic SD: Multiple antimelanoma potential of dry olive leaf extract. Int J Cancer. 128:1955–1965. 2011. View Article : Google Scholar
12	Fares R, Bazzi S, Baydoun SE and Abdel-Massih RM: The antioxidant and anti-proliferative activity of the Lebanese Olea europaea extract. Plant Foods Hum Nutr. 66:58–63. 2011. View Article : Google Scholar : PubMed/NCBI
13	Corona G, Deiana M, Incani A, Vauzour D, Dessì MA and Spencer JP: Inhibition of p38/CREB phosphorylation and COX-2 expression by olive oil polyphenols underlies their anti-proliferative effects. Biochem Biophys Res Commun. 362:606–611. 2007. View Article : Google Scholar : PubMed/NCBI
14	Han J, Talorete TP, Yamada P and Isoda H: Anti-proliferative and apoptotic effects of oleuropein and hydroxytyrosol on human breast cancer MCF-7 cells. Cytotechnology. 59:45–53. 2009. View Article : Google Scholar : PubMed/NCBI
15	Acquaviva R, Di Giacomo C, Sorrenti V, Galvano F, Santangelo R, Cardile V, Gangia S, D'Orazio N, Abraham NG and Vanella L: Antiproliferative effect of oleuropein in prostate cell lines. Int J Oncol. 41:31–38. 2012.PubMed/NCBI
16	Chan SL and Yu VC: Proteins of the bcl-2 family in apoptosis signalling: From mechanistic insights to therapeutic opportunities. Clin Exp Pharmacol Physiol. 31:119–128. 2004. View Article : Google Scholar : PubMed/NCBI
17	Nakano A, Tani E, Miyazaki K, Yamamoto Y and Furuyama J: Matrix metalloproteinases and tissue inhibitors of metallopro-teinases in human gliomas. J Neurosurg. 83:298–307. 1995. View Article : Google Scholar : PubMed/NCBI
18	Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell. 74:609–619. 1993. View Article : Google Scholar : PubMed/NCBI
19	Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HL, Prévost MC, Xie Z, Matsuyama S, Reed JC, et al: Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:2027–2031. 1998. View Article : Google Scholar : PubMed/NCBI
20	Gialeli C, Theocharis AD and Karamanos NK: Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar
21	Kettenmann H, Hanisch UK, Noda M and Verkhratsky A: Physiology of microglia. Physiol Rev. 91:461–553. 2011. View Article : Google Scholar : PubMed/NCBI
22	Opferman JT and Korsmeyer SJ: Apoptosis in the development and maintenance of the immune system. Nat Immunol. 4:410–415. 2003. View Article : Google Scholar : PubMed/NCBI
23	Vaux DL, Cory S and Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:440–442. 1988. View Article : Google Scholar : PubMed/NCBI
24	Strasser A, Harris AW, Bath ML and Cory S: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:331–333. 1990. View Article : Google Scholar : PubMed/NCBI
25	Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X: Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science. 275:1129–1132. 1997. View Article : Google Scholar : PubMed/NCBI
26	Danial NN: BCL-2 family proteins: Critical checkpoints of apoptotic cell death. Clin Cancer Res. 13:7254–7263. 2007. View Article : Google Scholar : PubMed/NCBI
27	Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, et al: Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 397:441–446. 1999. View Article : Google Scholar : PubMed/NCBI
28	Du C, Fang M, Li Y, Li L and Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:33–42. 2000. View Article : Google Scholar : PubMed/NCBI
29	Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ and Vaux DL: Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 102:43–53. 2000. View Article : Google Scholar : PubMed/NCBI
30	Li LY, Luo X and Wang X: Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 412:95–99. 2001. View Article : Google Scholar : PubMed/NCBI
31	Baffy G, Miyashita T, Williamson JR and Reed JC: Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem. 268:6511–6519. 1993.PubMed/NCBI
32	Hennet T, Bertoni G, Richter C and Peterhans E: Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 53:1456–1460. 1993.PubMed/NCBI
33	Lam M, Dubyak G, Chen L, Nuñez G, Miesfeld RL and Distelhorst CW: Evidence that BCL-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca²⁺ fluxes. Proc Natl Acad Sci USA. 91:6569–6573. 1994. View Article : Google Scholar
34	Zhang N, Wang X, Huo Q, Li X, Wang H, Schneider P, Hu G and Yang Q: The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) in breast cancer. J Biol Chem. 288:9396–9407. 2013. View Article : Google Scholar : PubMed/NCBI
35	Crompton M: Bax, Bid and the permeabilization of the mitochondrial outer membrane in apoptosis. Curr Opin Cell Biol. 12:414–419. 2000. View Article : Google Scholar : PubMed/NCBI
36	Habibović S, Hrgović Z, Bukvić I and Hrgović I: Molecular mechanisms in apoptosis. Med Arh. 54:33–40. 2000.In Croatian.
37	Antonsson B: Bax and other pro-apoptotic Bcl-2 family 'killer-proteins' and their victim the mitochondrion. Cell Tissue Res. 306:347–361. 2001. View Article : Google Scholar : PubMed/NCBI
38	Himelstein BP, Lee EJ, Sato H, Seiki M and Muschel RJ: Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: Involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin Exp Metastasis. 16:169–177. 1998. View Article : Google Scholar : PubMed/NCBI
39	Hu Y and Ivashkiv LB: Costimulation of chemokine receptor signaling by matrix metalloproteinase-9 mediates enhanced migration of IFN-alpha dendritic cells. J Immunol. 176:6022–6033. 2006. View Article : Google Scholar : PubMed/NCBI
40	Kallakury BV, Karikehalli S, Haholu A, Sheehan CE, Azumi N and Ross JS: Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma. Clin Cancer Res. 7:3113–3119. 2001.PubMed/NCBI
41	Wang F, Zhang P, Yang L, Yu X, Ye X, Yang J, Qian C, Zhang X, Cui YH and Bian XW: Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells. Am J Transl Res. 7:607–615. 2015.PubMed/NCBI
42	Zhang Z, Lv J, Lei X, Li S, Zhang Y, Meng L, Xue R and Li Z: Baicalein reduces the invasion of glioma cells via reducing the activity of p38 signaling pathway. PLoS One. 9:e903182014. View Article : Google Scholar : PubMed/NCBI
43	Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and González-Barón M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI
44	Fang Z, Tang Y, Jiao W, Xing Z, Guo Z, Wang W, Shi B, Xu Z and Liu Z: Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway. Food Chem Toxicol. 60:246–251. 2013. View Article : Google Scholar : PubMed/NCBI
45	Vier J, Groth M, Sochalska M and Kirschnek S: The anti-apoptotic Bcl-2 family protein A1/Bfl-1 regulates neutrophil survival and homeostasis and is controlled via PI3K and JAK/STAT signaling. Cell Death Dis. 7:e21032016. View Article : Google Scholar : PubMed/NCBI
46	Morgensztern D and McLeod HL: PI3K/Akt/mTOR pathway as a target for cancer therapy. Anticancer Drugs. 16:797–803. 2005. View Article : Google Scholar : PubMed/NCBI
47	Carrera-González MP, Ramírez-Expósito MJ, Mayas MD and Martínez-Martos JM: Protective role of oleuropein and its metabolite hydroxytyrosol on cancer. Trends Food Sci Technol. 31:92–99. 2013. View Article : Google Scholar